Pediatric Human Immunodeficiency Virus Continuum of Care: A Concise Review of Evidence-Based Practice

Megan E Gray1, Phillip Nieburg2, Rebecca Dillingham1

  • 1Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA 22908-1340, USA.

Insights

Caring for children and adolescents with human immunodeficiency virus (HIV) requires unique strategies. Addressing age-specific barriers to antiretroviral therapy (ART) is crucial for sustained viral suppression and a normal lifespan.

Area of Science:

  • Pediatric infectious diseases
  • Adolescent medicine
  • Public health

Background:

  • Children and adolescents with HIV require specialized care approaches.
  • Key stages include prevention, testing, antiretroviral therapy (ART) initiation, and ongoing engagement.
  • Age-specific barriers must be addressed for successful long-term viral suppression.

Purpose of the Study:

  • To highlight the unique challenges and necessary strategies in providing HIV care for pediatric and adolescent populations.
  • To emphasize the importance of addressing age-specific barriers throughout the continuum of HIV care.
  • To underscore the potential for a normal lifespan with sustained ART.

Main Methods:

  • This is a review and synthesis of current knowledge and best practices in pediatric and adolescent HIV care.
  • Focuses on critical steps: prevention, testing, ART initiation, retention, and engagement.
  • Examines common struggles such as ART adherence, disclosure, and stigma.

Main Results:

  • Successful HIV care for youth necessitates addressing unique age-related barriers.
  • Adherence to ART, disclosure of HIV status, and stigma are significant challenges for youth, families, and providers.
  • Multifaceted approaches and careful care transitions are essential.

Conclusions:

  • With sustained antiretroviral therapy (ART), youth living with HIV can achieve long-term health and a normal lifespan.
  • Effective HIV management in young people requires tailored strategies and comprehensive support.
  • Continued research and implementation of best practices are vital for improving outcomes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377